Table 3.
Electrostatic complementarity analysis results for L3 with each of the selected targets.
| Compounds | EC | EC r | EC rho |
|---|---|---|---|
| L3-6LU7 (Covid-19-main-protease) | 0.21 | 0.377 | 0.254 |
| L3- 7EXM (nsp2) | 0.17 | -0.045 | -0.106 |
| L3- 7JLT (nsp 7) | 0.068 | -0.229 | -0.204 |
Electrostatic complementarity analysis results for L3 with each of the selected targets.
| Compounds | EC | EC r | EC rho |
|---|---|---|---|
| L3-6LU7 (Covid-19-main-protease) | 0.21 | 0.377 | 0.254 |
| L3- 7EXM (nsp2) | 0.17 | -0.045 | -0.106 |
| L3- 7JLT (nsp 7) | 0.068 | -0.229 | -0.204 |